Lung Fung Group Holdings Limited (HKG:2290)

Revenue by Segment

Financials in millions HKD. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023
Retail - Drugs	3.28B	2.46B	2.02B	1.09B
Total	3.28B	2.46B	2.02B	1.09B

Revenue by Geography

Financials in millions HKD. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023
Hong Kong	3.24B	2.41B	1.98B	1.04B
Chinese Mainland	37.99M	47.62M	42.65M	51.38M
Total	3.28B	2.46B	2.02B	1.09B

Data Source: S&P Global Market Intelligence Last updated: Nov 28, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 20, 2026

Data Sources Report a data error